Atrial fibrillation (AF) is an important risk factor for ischemic stroke resulting in a fivefold
increased stroke risk and a twofold increased mortality. Our understanding of stroke …

Atrial fibrillation (AF) is a worldwide epidemic associated with significant morbidity and
mortality, often due to disabling or fatal thromboembolic stroke. Oral anticoagulation is highly …

Background Surgical exclusion of the left atrial appendage (LAA) can frequently yield
incomplete closure. Objective We evaluated the ischemic stroke/systemic embolization …

Background Watchman and Lariat left atrial appendage (LAA) occlusion devices are
associated with LAA leaks postdeployment. Objective The purpose of this study was to …

Transcatheter left atrial appendage (LAA) closure is an alternative to long-term
anticoagulation therapy in selected patients with nonvalvular atrial fibrillation who have an …

Objectives The aim of this study was to assess the feasibility and efficacy of transcatheter
leak closure with detachable coils in patients with incomplete left atrial appendage (LAA) …

Left atrial appendage (LAA) closure has recently been approved as an alternative
management for stroke prevention in patients with chronic atrial fibrillation who have …

Background Percutaneous left atrial appendage (LAA) occlusion with Lariat has emerged as
a viable alternative to oral anticoagulation (OAC) to prevent thromboembolic (TE) events in …

Objectives: The aim of this study was to evaluate the incidence and clinical implications of
leaks (acute incomplete occlusion, early and late reopenings) following LAA ligation with the …

Objectives: This study sought to assess long-term clinical outcomes in adults with
nonvalvular atrial fibrillation (AF) who are ineligible for oral anticoagulation therapy and …